News in Brief

MilliporeSigma opens $115m life science centre in Massachusetts

By Staff Reporter

- Last updated on GMT

GettyImages/Feverpitched
GettyImages/Feverpitched

Related tags: Life

MilliporeSigma has cut the ribbon on a life science site in Burlington that incorporates a biomanufacturing equipment education centre.

Ground was broken on the 280,000 sq ft facility in Burlington, Massachusetts in July 2016​, and 15 months later MilliporeSigma – the life science division of Germany’s Merck – has opened the doors on its $115m (€97m) investment.

The site will serve as a hub for drugmakers looking to find solutions for their bioprocessing needs, MilliporeSigma said, and includes an “M Lab Collaboration Center” ​offering a full-scale non-GMP pilot lab and process development lab expected to serve more than 500 customers per year.

CEO Udit Batra said the campus “is specifically designed to foster a hands-on, collaborative environment where customers and our scientists and engineers come together to solve the toughest problems in life science.”

Burlington replaces the company’s nearby Billerica lab, with 850 full-time employees currently at the relocating to the new campus.

The M Lab concept is being launched globally with MilliporeSigma offering the same services across eight sites from France to South Korea.

Related news

Show more

Related products

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the...

Partner with Experts in Precision Medicine

Partner with Experts in Precision Medicine

CellCarta | 17-Jan-2022 | Product Brochure

At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. Our broad technology offering is designed...

Related suppliers

Follow us

Products

View more

Webinars